Open for Registration
Demo OpportunitySGLT2 Inhibitors in Heart Failure — Systematic Review & Meta-Analysis
A structured SRMA group evaluating cardiovascular and renal outcomes of SGLT2 inhibitors in patients with heart failure, following PRISMA methodology with supervised task allocation.
- Specialty
- Medicine — Cardiology
- Study Type
- Systematic Review & Meta-Analysis
- Duration
- 5–7 months
- Level
- Intermediate
- Mode
- Online + Live Sessions
- Language
- English
- Current Stage
- Screening (Title & Abstract)
- Commitment
- 4–6 hours per week, with two live sessions per month.
Objectives
- Synthesise randomised evidence on major cardiovascular outcomes.
- Assess heterogeneity across ejection-fraction subgroups.
- Produce a methodologically defensible manuscript draft.
Program Model
- Recorded content library
- Bi-weekly live methodology meetings
- Assigned tasks with deadlines
- Supervisor review of each deliverable
- Dedicated project communication channel
Educational Outputs
- Recorded methodology modules (protocol, search, screening, RoB).
- Hands-on supervised practice on the live project.
- Certificate of completion based on documented task delivery.
Research Outputs
- PROSPERO-style protocol draft
- Reproducible search strategy
- Analysis outputs, tables and figures
- Manuscript draft prepared for submission (no acceptance promised)
Eligibility & Experience
- Medical, pharmacy or allied health background (student or graduate).
- Working proficiency in scientific English.
- Ability to meet task deadlines and participate in review rounds.
Mentors & Supervisors
Placeholder — Methodology Lead
Systematic Review Methodologist
Demo profilePlaceholder — Biostatistician
Meta-Analysis & Statistics
Demo profileAuthorship policy
Registration and payment never automatically grant authorship. Authorship positions are determined solely by documented contribution, completion of assigned tasks, participation in review rounds, and final approval and accountability for the submitted work.